Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: Different behavior patterns?

Journal of Endocrinological Investigation

Volumn 25, Issue 3, 2002, Pages 214-223

  Pittoni, G ^a   Gallioli, G ^b   Zanello, M ^c   Gianotti, L ^d   Boghen, M F ^e   Colombo, S ^b   Broglio, F ^d   Santoro, C ^c   Davia G ^a   Papini, M G ^e   Destefanis, S ^d   Minuto, F ^f   Miola, C ^e   Ghigo, Ezio ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Mantova Hospital   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e PFIZER INC   (United States)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Critical illness; GH; IGFBPs; IGFs; Nutrition; Sepsis; Trauma

Indexed keywords

ALBUMIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE RELEASING FACTOR; PREALBUMIN; RETINOL BINDING PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFERRIN;

ADULT; AGED; ARTICLE; ARTIFICIAL FEEDING; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RESISTANCE; HORMONE RESPONSE; HUMAN; INJURY; INTENSIVE CARE UNIT; MALE; NUTRITIONAL HEALTH; NUTRITIONAL PARAMETERS; SEPSIS;

ADULT; AGED; CARRIER PROTEINS; CRITICAL ILLNESS; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INTENSIVE CARE; MALE; MIDDLE AGED; NUTRITIONAL SUPPORT; PREALBUMIN; PROSPECTIVE STUDIES; SEPSIS; SERUM ALBUMIN; TIME FACTORS; WOUNDS AND INJURIES;

EID: 0036214686     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343993     Document Type: Article

References (47)

1. Catabolic illness
2. The endocrinology of the critically ill
3. Anterior pituitary function during critical illness and dopamine treatment
4. Growth hormone secretion in critical illness: Effect of dopamine
5. Acquired growth hormone resistance
6. Pituitary-thyroid axis in critical illness
7. Nutritional regulation of insulin-like growth factors
8. Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins
9. Insulin-like growth factor-I blood levels in severely burned patients: Effects of time post injury, age of patient and severity of burn
10. Insulin-like growth factor-I production is inhibited in human sepsis
11. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery
12. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease
13. Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions
14. Biosynthetic human growth hormone in burned patients: A pilot study
15. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury
16. Effects of recombinant human growth hormone in patients with severe sepsis
17. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I
18. Plasma levels of insulin-like growth factor binding protein-3 in acute trauma patients
19. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: A double-blind, randomized controlled study
20. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation
21. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection
22. Effects of human growth hormone on the catabolic state after surgical trauma
23. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system
24. Disturbed anabolic hormonal patterns in burned patients: The relation to glucagon
25. Growth hormone and cortisol secretion in patients with burn injury
26. Time course and variability of the endocrine and metabolic response to severe sepsis
27. Pulsatile nature of growth hormone levels in critically ill trauma victims
28. Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome
29. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary
30. Physiology of growth hormone secretion and action
31. Neurotransmitter control of growth hormone secretion
32. Growth hormone (GH)-releasing peptides
33. Pituitary responsiveness to GH-releasing peptide-2 and thyrotropin-releasing hormone in critical illness
34. Growth hormone, insulin-like growth factor-I, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease
35. Measurement of gas exchange in intensive care: Laboratory and clinical validation of a new device
36. Insulin-like growth factors and their binding proteins: Biological actions
37. Metabolic and therapeutic effects of insulin-like growth factor I
38. Response of IGF-I to nutritional support in malnourished hospital patients: A possible indicator of short-term changes in nutritional status
39. The rationale for the use of recombinant human growth hormone and insulin-like growth factor-I for catabolic conditions in humans
40. Circulating growth hormone binding proteins
41. The energy expenditure of the mechanically ventilated critically ill patient
42. Transport proteins as indices of protein status
43. Cytokines and endocrine function: An interaction between the immune and neuroendocrine systems
44. Sepsis and cytokines: Current status
45. Measurement of prealbumin as index of protein-calorie malnutrition
46. The role of retinol-binding protein in protein-calorie malnutrition
47. Temporal structure of in vivo growth hormone secretory events in humans